1 / 4

Healthcare, Regulatory and Reimbursement Landscape - Belgium

This report provides insights into the healthcare, regulatory, and reimbursement landscape in Belgium. It highlights key trends in the healthcare market, demographics, regulations, and healthcare infrastructure, with a focus on the pharmaceutical and medical device markets. The report is based on data from proprietary databases, secondary research, and industry experts' analysis.

petersonr
Download Presentation

Healthcare, Regulatory and Reimbursement Landscape - Belgium

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Healthcare, Regulatory and Reimbursement Landscape - Belgium Bharat Book Bureau

  2. Summary • Industry analysis specialist GlobalData has released its latest report “Healthcare, Regulatory and Reimbursement Landscape - Belgium”. An essential source of information and analysis on the Belgian healthcare, regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, and reimbursement landscape and healthcare infrastructure. • Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research and in-house analysis by team of industry experts.

  3. Continue… • In 2012, Belgium had a population of 11 million. The pharmaceutical market was estimated to be worth $6.32 billion in 2013 at consumer-price level (including Value Added Tax (VAT) and excluding hospital sales) and is expected to reach $6.77 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 0.98%. The medical device market was worth approximately $2.44 billion in 2013 and is expected to reach $3.41 billion by 2020 at a CAGR of 4.9%. • These positive trends can primarily be attributed to - - R&D investment- A conducive regulatory environment- Fast approval process and high-quality research, which attract companies wanting to conduct clinical trials- Increasing burden of elderly care- High per-capita healthcare expenditure

  4. Interesting, right? This is just a sneak preview of the full presentation. We hope you like it! To see the rest of it, just click here to view it in full on PowerShow.com. Then, if you’d like, you can also log in to PowerShow.com to download the entire presentation for free.

More Related